Mingqian Feng Selected Research

Viral Antigens

1/2019

Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naïve nurse sharks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingqian Feng Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 10/2010
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2010
8	Liver Neoplasms (Liver Cancer) 01/2022 - 10/2010
4	Mesothelioma 04/2013 - 01/2011
2	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 11/2023
2	Ovarian Neoplasms (Ovarian Cancer) 05/2011 - 01/2011
2	Neoplasm Metastasis (Metastasis) 05/2011 - 01/2011
1	Epstein-Barr Virus Infections 07/2023
1	Hematologic Diseases (Blood Diseases) 07/2023
1	COVID-19 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 11/2022
1	Triple Negative Breast Neoplasms 07/2022
1	Breast Neoplasms (Breast Cancer) 07/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2019
1	Coronavirus Infections 01/2019
1	Severe Acute Respiratory Syndrome 01/2019
1	Type I Syndactyly 04/2013
1	Adenocarcinoma of Lung 05/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2011
1	Malignant Mesothelioma 01/2011
1	Cholangiocarcinoma 10/2010

Drug/Important Bio-Agent (IBA)

12	GlypicansIBA 01/2022 - 05/2011
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
8	Immunotoxins (Immunotoxin)IBA 11/2022 - 01/2011
7	MesothelinIBA 04/2024 - 10/2010
4	AntibodiesIBA 06/2015 - 01/2011
3	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2020
3	EpitopesIBA 11/2023 - 01/2011
3	Monoclonal AntibodiesIBA 07/2022 - 01/2011
3	AntigensIBA 01/2020 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2011
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2011
2	LuciferasesIBA 01/2020 - 03/2011
2	Peptides (Polypeptides)IBA 04/2013 - 01/2011
2	Single-Domain AntibodiesIBA 04/2013 - 03/2013
1	Interleukin-12 (IL 12)IBA 04/2024
1	Amino Acids FDA Link 08/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2022
1	B7-H1 AntigenIBA 07/2022
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Programmed Cell Death 1 ReceptorIBA 07/2022
1	roblitinibIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Immunoglobulin IsotypesIBA 07/2021
1	Immune Checkpoint ProteinsIBA 07/2021
1	VimentinIBA 01/2021
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2021
1	PerforinIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	CateninsIBA 10/2019
1	Cysteine (L-Cysteine)FDA Link 10/2019
1	human ERBB2 proteinIBA 01/2019
1	Viral AntigensIBA 01/2019
1	Drug CarriersIBA 06/2015
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 03/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 08/2014
1	Proteoglycans (Proteoglycan)IBA 08/2014
1	Complement System Proteins (Complement)IBA 04/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 05/2011
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	Immunoglobulin G (IgG)IBA 05/2011
1	RNA Polymerase II (RNA Polymerase B)IBA 03/2011
1	Bacterial ToxinsIBA 01/2011
1	MucinsIBA 01/2011

Therapy/Procedure

19	Therapeutics 04/2024 - 10/2010
5	Immunotherapy 07/2023 - 10/2010
2	Injections 11/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 07/2022 - 01/2020
1	Intraperitoneal Injections 01/2020
1	Orthoptics (Orthoptic) 01/2020
1	Radiotherapy 01/2020